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Abstract
Background: To investigate the effect of pelvic floor Neuromuscular Electrical Stimulation (NMES) Therapy in
improving endometrial thickness in women with thin endometrium.
Methods: 41 patients undergoing assisted reproduction with a thin endometrium (less than or equal to7 mm)
were recruited and advised to go for a pelvic floor NMES in frozen-thawed embryo transfer cycle. PHENIX
Neuromuscular Electrical Stimulation Therapy System was used according to the manufacturer’s recommended
protocol for 20 to 30 minutes of intermittent vaginal electrical stimulation on the treatment days.
Results: A total of 20 and 21 were included in the NMES and non-NMES groups respectively. 12 out of 20 (60%)
patients developed endometrial thickness equal to or more than 8 mm after the NMES therapy, which was the
primary outcome. The mean thickness of endometrium before and after was respectively 5.60 mm (0.82 mm) and
7.93 mm (1.42 mm) in the therapy group versus 5.50 mm (1.00) and 6.78 mm (0.47) in the control group; the
difference was statistically significant (P = 0.002). There was higher pregnancy rate in the NMES group (42% versus
35%) but the difference was not statistically significant.
Conclusion: Neuromuscular Electrical stimulation therapy may be effective for the patients with a thin
endometrium. Further studies are needed to investigate its effectiveness.
Background
B yt h et i m eo fo v u l a t i o n ,m a n ya s s i s t e dr e p r o d u c t i v e
technologies (ART) practitioners like to see the endome-
t r i u ma tl e a s t8m mt h i c k .A na d e q u a t ee n d o m e t r i u m
thickness and appearance play a key role in the implan-
tation of embryo and achievement of pregnancy [1-3].
There is no officially accepted definition of “thin lining”.
The commonly accepted cut off would be less than 8
mm on the day of LH surge or HCG administration day
[4]. Thin endometrium at the time of ovulation can be a
concern and has been demonstrated to be an important
factor in implantation failure [5]. The exact mechanism
of implantation failure is unknown but might be related
to an overall poor intrauterine environment. Factors
affecting the growth of endometrium are still not well
understood, but recently many researchers have focused
on the angiogenesis and vascularization within the endo-
metrium and found that a poor uterine receptivity in
women with thin endometrium may be due to the
impairment of blood flow impedance through the endo-
metrium [6-9]. Recent studies have focused on different
treatment modalities which include exogenous estrogen
[10], low-dose aspirin [11-13], vaginal sildenafil citrate
[14], pentoxifylline, vitamin E, L-arginine [9,15,16],
gonadotropin-releasing hormone agonist [17], electroa-
cupuncture [8] and cytokine (granulocyte colony stimu-
lation factor) [18] for the management of women with
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tion and pregnancy rates in ART cycles. Although there
are many studies concerning different managements of
women with thin endometrium to modulate uterine
artery blood flow and improve endometrial thickness,
there is no agreement in the literature about a consen-
sus treatment.
Up to date, no study has evaluated the use of Pelvic
floor neuromuscular electrical stimulation (NMES) in
reproductive medicine. NMES has been used in urogy-
necology and obstetrics during pregnancy and postpar-
tum period. There is a strong evidence for its
effectiveness for treatment of stress urinary incontinence
(SUI), pelvic pain, sexual dysfunction, low back pain and
constipation in clinical practice [19]. NMES is the appli-
cation of electrical stimulation to a group of muscles
through electrodes placed on the skin. It is the elicita-
tion of muscle contraction using electric impulses. The
impulses are generated by a device and delivered
through electrodes on the skin in direct proximity to
the muscles to be stimulated. Long-term data reported
that the rate of patients cured or patient’sc o n d i t i o n s
improved from electrical stimulation ranged from 54-
77% [20]. The purpose of this study was to investigate
whether thin endometrium can be improved by pelvic
floor NMES.
Methods
The study was reviewed and approved by the Ethical
Review Board of the Memorial Hospital of Sun Yat-Sen
University. Written informed consent was obtained from
all patients.
Subjects and study design
This study was an observational and prospective study.
It was carried out in the reproductive center of the
Memorial Hospital of Sun Yat-Sen University (Guangz-
hou, China) from December 2009 to April 2011.
Women were eligible for the study if they were 20 to 39
years old, if they were recorded at least 2 previous
assisted reproductive treatment cycle failures in which
the optimum endometrium thickness was ≤ 7m ma n d
were undergoing frozen-thawed embryo transfer in hor-
mone replacement therapy (HRT) cycle.
Women were excluded from participation if they had
a medical history that included pelvic cancer, severe
endometriosis, Asherman’s syndrome, adenomyosis, or
congenital uterine anomaly, use of an intrauterine
device, vaginitis, neurologic disorders, systemic diseases,
hypertension or diabetes mellitus. Exclusion based on
physical examination by the nurse practitioner (the phy-
sical therapist) occurred if women had vaginal wall pro-
lapse, skin breakdown around the peri-anal region,
rectal or vaginal bleeding, or absolute contraindications
for pelvic neuromuscular electrical stimulation such as
complete denervation of the pelvic floor (will not
respond), dementia, cardiac pacemaker, unstable or ser-
ious cardiac arrhythmia, unstable seizure disorder, pelvic
pain and painful hemorrhoids.
A total of 41 women with a history of infertility and
who had a thin endometrial (endometrial thickness ≤7
mm in the late follicular phase) in their previous treat-
ment cycles were recruited into this study. This thresh-
old was chosen based on studies in the literature
reported reduced implantation and pregnancy rates
when endometrial thickness was 7 mm and less[5,21,22].
All the women were advised to go for a pelvic floor
NMES therapy from day9 or day10 for 3 to 4 times con-
secutively (qd for 20-30 minutes). 20 women accepted to
t r yN M E S .T h ec h o i c eo ft h ep a t i e n t sn o tt og of o r
NMES did not affect their further treatment.
All the women received previously a standard regime of
the GnRH agonist with the use of (Triptorelin) and gona-
dotropins (Gonal-F). Human chorionic gonadotropin
(10.000 IU) was administered intramuscularly when lead
follicles were ≥ 18 mm in diameter, and there were at
least three follicles 16 mm in diameter (IVF/ICSI). 30-36
h after injections of HCG, oocyte was retrieved guided by
transvaginal ultrasound. They had a fresh embryo trans-
fer cycle failure and at least one frozen-thawed embryo
transfer (FET) cycles on natural cycle, ovulation induc-
tion cycle or on artificial cycle without success.
Endometrial preparation in HRT cycle
Estradiol valerate (E2) 2 mg/day (Progynova; Bayer
Schering Pharma, France) was commenced orally on day
3 of menstruation cycle without prior pituitary suppres-
sion and continued for 5 days. After 5 days (day8), the
dose of progynova was changed to 2 mg bid for 3 days.
On day10 of menstruation cycle, endometrial thickness
was assessed by ultrasound. If the endometrial thickness
was ≤8 mm, the dose of progynova was increased to 3
mg bid for 3-5 days, after which the endometrial thick-
ness was evaluated for the second time. If the endome-
trial thickness was still ≤8 mm, the dose was increased
to 5 mg bid until the endometrial thickness reached 8
mm. If the endometrium thickness reached 8 mm, the
luteal phase support was started (D0) by providing pro-
gesterone (60 mg daily by intramuscular injection or 90
mg of progesterone sustained-release vaginal gel, daily
for 17 days) to all patients. If the endometrial thickness
failed to reach 7 mm after 20 days of progynova use, the
cycle was usually cancelled and restarted in a new pro-
tocol (natural cycle or ovulation induction cycle), but
the final decision was given to patient to go forward for
the embryo transfer or cancel the cycle. All the embryos
transfer were performed on D3 (72 h after beginning
progesterone supplementation).
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Guide for pelvic floor muscles contraction
The women were told to lie down in the supine posi-
tion, lithotomy position, on an examination bench with
the legs extended. The nurse practitioner (physical
therapist) examined all participants prior to therapy.
The physical therapist instructed them how to contract
and relax the pelvic floor muscles. A digital vaginal
exam was used to help the physical therapist make sure
whether the patient successfully contracted the right
muscles or not and determine the degree of muscles
strength by contraction or compression of examiner’s
fingers. Each contraction should involve a concentrated
effort to get maximum tightening. Patients were
instructed to contract only the pelvic floor muscles. If
they feel their abdomen, thighs or buttocks tightening
then they were asked to relax and aim just for the pelvic
muscles by using a less intense muscle contraction. The
women were encouraged through detailed and explicit
instructions and directions by the physical therapist.
Therapy posture
The patient still in supine position with one cushion
under the head and the legs opened up, both of the legs
forming 40° approximately. Two other cushions of
about 5-10 cm height were inserted under the knees to
prevent the thigh muscles from participating in contrac-
tion of pelvic muscles. An ointment (electrical conduc-
tance gel) was applied to the tip of the probe before its
insertion into the vagina. The probe was inserted to
about 6-8 cm deep. The vaginal probe was fixed on the
probe box, situated between the two cushions, to avoid
squeezing it out of the vagina. All the women had their
own vaginal probe (Guangzhou Shanshan Medical
Apparatus and Instruments Industry CO. LTD
ZL2005201203870, China). Adhesive electrodes were
placed on the skin outside the vagina (on the women’s
thigh). Vaginal probe was kept in vagina and electrical
stimulation was initiated.
Neuromuscular electrical stimulation and biofeedback
therapy
PHENIX Neuromuscular Electrical Stimulation Therapy
System USB 4 (Guangzhou Shanshan medical apparatus
and instruments industry CO. LTD, Guangzhou, China)
was used according to the manufacturer’s recommended
protocol for 20 to 30 minutes of intermittent vaginal
electrical stimulation on the treatment days. Selected
parameters included biphasic intermittent current, fre-
quency 40 Hz, pulse width 250 us, and current intensity
between 0-120 mA with individually adapted on-off
(duty) cycles on the basis of each woman’s ability to
hold a voluntary contraction. On time ranged from 3
seconds to 10 seconds, and off time from 0 second to
30 seconds. For biofeedback therapy, computer graphs
were used to help them locate the pelvic muscles. All
patients were encouraged to tolerate as high intensity as
possible to get a contraction.
Kegel Maneuvers
After the first therapy, the women were instructed to
practice exercises at home. The exercise program con-
sisted on to hold each contraction for 1 second and
then to relax the muscles for 5 seconds. This sequence
was repeated continuously for 15 minutes. The women
were told to do the exercise in lying position so that
there is little stress on the muscles. Two training repeti-
tions were performed in the presence of the physical
therapist.
Endometrial evaluation
Endometrial thickness was measured at its thickest part
in the longitudinal axis of the uterus before (day9 or day
10) and after NMES therapy (D0, the start of progester-
one supplementation for FET) in the two groups. The
endometrial pattern visualized was designated as a mul-
tilayered or a non-multilayered endometrium. The mea-
surements were performed by one investigator (C.Z)
using a computerized vaginal ultrasound with an inte-
grated pulsed Doppler vaginal scanner (Aloka Prosound
SSD-3500., Japan). CZ was blind to the conditions of
the patients.
Statistical analysis
Mean and standard deviation were used for description
of variables. A student’s t test was used to compare the
difference between groups. Comparison of before and
after treatment endometrial thickness in the NMES
group was performed using Non-parametric Wilcoxon
test. Statistical comparison for percentage was carried
out by chi-square. All the statistical analyses were car-
ried out using SPSS software (Statistical Package for
Social Sciences, SPSS Inc, Chicago, IL, USA) version
16.00. A p value < 0.05 (two tailed) was considered to
be statistically significant.
Results
General characteristics of the study population
The general characteristics of the study subjects are
shown in Table 1. A total of 20 and 21 women were
included in the NMES and nonNMES treatment groups,
respectively. Their mean age was 30.10 ± 3.97 years
(range 24-39). Their mean body mass index was 20.44 ±
2.55 kg/m
2 (range 16.60-27.20). The women in this
study had mixed diagnosis. 24/41(58.5%) had primary
infertility. 19 women out of 41 were diagnosed polycys-
tic ovary syndrome (PCOS). 31 had tubal occlusion, and
29 with male factor. The mean age and endometrial
thickness at baseline (day9) of the two groups showed
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30.62 ± 4.54 years; 5.60 ± 0.82 mm versus 5.50 ± 1.00
mm) (Table 1)
Primary outcome
After the NMES therapy, the endometrium became
thickened in the NMES group (7.93 ± 1.42 versus 6.78
± 0.47; P = 0.002) which was statistically significant. The
majority of patients in the NMES group showed an
improvement in the endometrial thickness. 12/20(60%)
patients developed endometrial thickness equal to or
more than 8 mm after NMES therapy, which was the
primary outcome. 3 out of 20 did not respond to the
therapy(no change was observed in their endometrium
thickness during the cycle).
Secondary outcome
“Regarding the clinical pregnancy rate, 42% (8/19) and
35% (7/20) conceived in the NMES group and non-
NMES group respectively. There was no significant dif-
ference between the NMES group and nonNMES group
(Table 1). The mean thickness endometrium in women
who conceived was 7.79 ± 1.13 mm, the one in non-
pregnant women 7.18 ± 1.18 and the women who con-
ceived were younger than the ones who did not (28.67 ±
2.44 versus 30.92 ± 4.94) but the differences were not
statistically significant (Table 2).
2 women (1 in the NMES group and 1 in the non-
NMES group) had embryo transfer cancelled because of
a poor embryo quality.
Discussion
NMES is the application of electrical stimulation to a
group of muscles through electrodes placed on the skin.
It is the elicitation of muscle contraction using electric
impulses. The impulses are generated by a device and
delivered through electrodes on the skin in direct proxi-
mity to the muscles to be stimulated. The impulses
mimic the action potential coming from the central ner-
vous system, causing the muscles to contract. It was pri-
marily used by physical therapists to help restore
function to injured muscles. Now the utilization of
NMES is a routine practice in urology (incontinence)
and in gynecology & obstetrics (pelvic pain, dyspareu-
nia) all over the world [23-25]. The effectiveness of pel-
vic-floor strengthening exercise and electrical
stimulation in the management of SUI is well estab-
lished [25,26]. To the best of our knowledge, this is the
first study investigating physical therapy, pelvic floor
NMES to improve endometrial growth in women with
thin endometrium. We have shown that NMES could be
an effective option to manage women with thin endo-
metrium. All of the patients reported in this study had a
least two prior failed ART treatment and none of them
had previously shown an endometrium thickness >7
mm. Our study showed that pelvic floor NMES signifi-
cantly enhances endometrial thickness in patients with
thin endometrium. Uterine blood flow has been showed
to be an important factor for endometrial growth. It is
therefore likely that NMES corrects the impairment of
uterine blood flow impedance. Most of the women who
Table 1 Comparison of Age, BMI, Waist, Baseline hormones profile, Endometrial Thickness, and Pregnancy Rate in
NMES and nonNMES Groups
Parameters NMES GROUP (n = 20) nonNMES Group (n = 21) P value
Age (years) 29.75 +/- 3.95 30.62 +/- 4.54 0.516
BMI (Kg/m
2) 20.44 +/- 1.94 20.45 +/- 3.10 0.987
Waist (cm) 72.03 +/- 4.94 71.10 +/- 7.75 0.663
bFSH (IU/ml) 7.03 +/- 3.09 8.20 +/- 3.69 0.296
bLH (IU/ml) 9.70 +/- 7.68 6.72 +/- 5.50 0.174
bE2 (ng/ml) 54.75 +/- 47.34 64.16 +/- 51.90 0.563
bT (nmol/l) 1.75 +/- 1.01 1.71 +/- 0.67 0.874
Infertility
Primary 11(55%) 13(61.9%)
Duration of infertility (years) 3.85 +/- 2.78 5.40 +/- 3.22 0.111
Tubal factor 14(70%) 17(81%)
Male factor 10(50%) 19(90%)
PCOS 12(60%) 7(33.3%)
Endometrium thickness at day10 (mm) 5.60 +/- 0.82 5.50 +/- 1.00 0.731
Endometrium thickness at Day 0 (mm) 7.93 +/- 1.42 6.78 +/- 0.47 0.002
Pregnancy rate (%) 8(42%) 7(35%) 0.748
Number of Embryos transferred 1.85 +/- 0.49 2.43 +/- 0.75 0.006
Data are shown as mean +/- standard deviation and number (percentage). Day 0: start of progesterone supplementation in HRT cycle. HRT: Hormone
replacement therapy. PCOS: Polycystic ovarian syndrome. P < 0.05 was statistically significant.
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able improvement in the endometrium thickness.
Little information is available regarding the exact
mechanisms by which NMES exerts its function on the
process of angiogenesis and vascularization in the endo-
metrium. However, based on the data in the literature
on the importance of angiogenesis and vascularization
for a receptive uterine, we believe that by stimulating
uterine smooth muscle to repeated contraction and
relaxation, there is an increased in blood supply towards
the whole endometrial and the sub-endometrial regions
that leads to peripheral tissue trophicity. NMES provides
a passive contraction that increases awareness of pelvic
floor muscles contractions in general. The etiology of
thin endometrium is complex, multifactorial and
remains unclear. High blood flow impedance of uterine
radial arteries and decreased in vascular endothelial
growth factor (VEGF) expression are associated with
poor endometrial growth [21]. The inadequate endome-
trial thickness might be due also to either fewer estro-
gen receptors or the desensitization of estrogen
receptors. The important point for treatment in case of
blood impedance is starting the treatment at the first
day of the menstrual cycle. However, NMES was started
from day 9 or day10 in the treatment cycle in the pre-
sent study, to make sure that menstruation had stopped
and to avoid excessive bleeding if done during the men-
struation period; vaginal bleeding or any internal or
external sign of hemorrhage being one of the contrain-
dications for NMES therapy.
With this method, the endometrial thickness was sig-
nificantly increased and we achieved a pregnancy rate as
high as 42%(8/19). Our results are with agreement to
those that reported a positive correlation between endo-
metrial thickness and pregnancy rate[3,5,21,22].
In this study, only 3 women did not respond at all to
NMES. The uniqueness of this study is that it
demonstrated a speedy and significant increase in endo-
metrial thickness. NMES was performed only 3 to 4
times for 20-30 min in the subsequent cycle (once per
day consecutively). The number or amount of time of
therapy needed to show improvement varies from per-
son to person. NMES therapy was stopped as soon as
the endometrial thickness reached 8 mm. Four times
therapy was the maximum we prescribed to the women
in this study. Other benefits include NMES being safe, it
is also a noninvasive technique and it appears as a pro-
mising alternative for managing patients with thin endo-
metrium. No known serious adverse effects have been
reported by the subjects.
Conclusions
Pelvic floor NMES showed a positive effect on the endo-
metrium thickness and the pregnancy rate, but there
may be too few subjects in the present study to draw a
firm conclusion. Further studies are doubtless needed in
this area to investigate this issue.
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Table 2 Comparison of Age, BMI, Waist, Baseline hormones profile, and Endometrial Thickness in Pregnant and
nonPregnant Groups
Parameters Pregnant women (n = 15) nonPregnant women (n = 26) P value
Age (years) 28.67 +/- 2.44 30.92 +/- 4.94 0.067
BMI (Kg/m
2) 20.85 +/- 2.53 19.78 +/- 2.13 0.170
Waist (cm) 73.39 +/- 4.47 69.27 +/- 6.09 0.036
bFSH (IU/ml) 7.16 +/- 3.60 7.88 +/- 3.49 0.554
bLH (IU/ml) 11.53 +/- 9.22 6.44 +/- 4.28 0.069
bE2 (ng/ml) 59.49 +/- 47.64 62.84 +/- 52.16 0.847
bT (nmol/l) 1.85 +/- 0.46 1.68 +/-1.03 0.499
Duration of infertility(years) 3.71 +/- 2.40 5.13 +/- 3.25 0.166
Endometrium thickness at day10 (mm) 5.64 +/- 0.93 5.46 +/- 0.93 0.559
Endometrium thickness at Day 0 (mm) 7.79 +/- 1.13 7.18 +/- 1.18 0.120
Number of Embryos transferred 2.2 +/- 0.41 2.29 +/- 0.55 0.583
Data are shown as mean +/- standard deviation and number (percentage). Day 0: start of progesterone supplementation in HRT cycle. P < 0.05 was statistically
significant.
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